• Home
  • Meet Our Providers
    • Tiffany Brown APRN
    • De'shanti McDonald LPN
  • Our Products
    • Products
    • Do I Qualify?
  • What To Expect
    • What to Expect
  • All Services
    • Urgent Care
    • Medical Weightloss
    • Peptides
  • More
    • Home
    • Meet Our Providers
      • Tiffany Brown APRN
      • De'shanti McDonald LPN
    • Our Products
      • Products
      • Do I Qualify?
    • What To Expect
      • What to Expect
    • All Services
      • Urgent Care
      • Medical Weightloss
      • Peptides
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Meet Our Providers
    • Tiffany Brown APRN
    • De'shanti McDonald LPN
  • Our Products
    • Products
    • Do I Qualify?
  • What To Expect
    • What to Expect
  • All Services
    • Urgent Care
    • Medical Weightloss
    • Peptides

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account
Brown Health & Wellness

Weighloss reimagined

Weighloss reimagined Weighloss reimagined Weighloss reimagined

CANDIDATES FOR SEMAGLUTIDE OR TIRZEPATIDE WEIGHT LOSS

ELIGIBLE FOR SEMAGLUTIDE WEIGHT LOSS TREATMENT:

This program is designed for adults 18 and older who are seeking weight‑loss support and meet basic medical safety criteria. Eligible clients include individuals with a BMI of 25 or higher, including those with well‑controlled type 2 diabetes. Participants must not be pregnant or breastfeeding and should have no history of pancreatitis, diabetic ketoacidosis, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome, or hypersensitivity to semaglutide. It is also intended for those without end‑stage renal disease or diabetic retinopathy.

TYPE-2 DIABETES MANAGEMENT

Semaglutide is an effective option for helping manage high blood sugar in individuals with type 2 diabetes. As a member of the antihyperglycemic class known as GLP‑1 receptor agonists, it supports glucose control by increasing insulin release, reducing glucagon levels, slowing gastric emptying, and helping curb appetite. Brown H&W Clinic only offers Semaglutide for weight loss treatment and does not actively treat Type-2 Diabetes.

ELIGIBLE FOR TIRZEPATIDE WEIGHT LOSS TREATMENT:

This program is designed for adults 18 and older who want structured, medically supervised weight‑loss support using tirzepatide. Candidates should have a BMI of 25 or higher and may include individuals with well‑managed type 2 diabetes. To ensure safety, participants must not be pregnant or breastfeeding and should have no history of pancreatitis, diabetic ketoacidosis, medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome. Tirzepatide is also not recommended for individuals with severe renal impairment, diabetic retinopathy, or known allergies to the medication or its components.

TYPE-2 DIABETES MANAGEMENT

Tirzepatide can help regulate high blood sugar levels in individuals with type 2 diabetes by acting as a dual GIP/GLP‑1 receptor agonist. It works through several pathways, including increasing insulin secretion, reducing glucagon production, slowing gastric emptying, and decreasing appetite. At Brown H&W Clinic, tirzepatide is used exclusively for weight‑management purposes and is not provided as a treatment for type 2 diabetes.

Contact Us

Have a question or want to schedule an appointment? Contact us today! Care as fast as 15 minutes.


Copyright © 2026 Brown Health & Wellness - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept